LOWLIGHT
  • Home
  • OVER ONS
  • THERAPIE
  • ONDERZOEK
  • TRAINING
  • MEDIA
  • CONTACT
  • Home
  • ABOUT US
  • THERAPY
  • RESEARCH
  • TRAINING
  • MEDIA
  • CONTACT

NEURO LIGHT

GOAL

Picture
Evaluation of the efficacy of photobiomodulation (PBM) therapy in the management of chemotherapy-induced neuropathy.

STUDY DESIGN

Picture
Randomized pilot trial with patients diagnosed with chemotherapy-induced neuropathy.  This study started in February 2022. 
Laser group 1 (n=15) 
Laser group 2 (n=15) 
PBM (2x/week, for 3 weeks)
PBM (2x/week, for 3 weeks)
Lasertherapy with a dosage of 6 J/cm²
Lasertherapy with a dosage of 8 J/cm²

STUDY RESULTS

Picture
Study is still active and no preliminary results are available.

PUBLICATIONS

Picture
 

PARTNERS

  • Home
  • OVER ONS
  • THERAPIE
  • ONDERZOEK
  • TRAINING
  • MEDIA
  • CONTACT
  • Home
  • ABOUT US
  • THERAPY
  • RESEARCH
  • TRAINING
  • MEDIA
  • CONTACT